GC rs4588: Understanding Your Vitamin D Binding Protein Variant
The rs4588 variant is a common genetic change located in the GC gene, which provides instructions for making the vitamin D binding protein. Research has consistently associated this variant with differences in the circulating levels of 25-hydroxyvitamin D in the blood.
What each genotype means
Typical 25-hydroxyvitamin D levels
You carry two copies of the C allele, which encodes the ancestral threonine at position 436 of the vitamin D-binding protein (often designated within the Gc1 isoform group). Genome-wide association studies consistently link this genotype with higher baseline circulating concentrations of total 25-hydroxyvitamin D relative to carriers of the A allele. These findings describe population-level statistical differences, and overall vitamin D status remains heavily governed by dietary intake, sun exposure, and lifestyle.
Carried by approximately 50% to 60% of individuals across global populations, being the most common genotype worldwide.
Moderately reduced 25-hydroxyvitamin D
You carry one copy of the A allele and one copy of the C allele in the GC gene. Research shows that each A allele is associated with an incremental reduction in circulating serum 25-hydroxyvitamin D and slight alterations in vitamin D-binding protein binding affinity. Because this effect is modest and represents an associative health predisposition rather than a clinical deficiency on its own, routine lab testing and guidance from a healthcare provider remain the standard way to evaluate vitamin D sufficiency.
Carried by roughly 35% to 40% of people globally, reflecting a minor allele frequency of approximately 0.28.
Lower 25-hydroxyvitamin D concentrations
You carry two copies of the A allele, corresponding to the Lys436 amino acid substitution defining the Gc2 electrophoretic protein isoform. Clinical and epidemiological studies observe that individuals homozygous for this allele tend to have the lowest average circulating 25-hydroxyvitamin D levels among rs4588 genotypes. This finding reflects a statistical association in population studies; any considerations regarding supplementation or assessing your nutritional status should be discussed with a qualified clinician.
Carried by approximately 5% to 9% of individuals globally, varying modestly by ancestral background.
What is the rs4588 Variant?
The rs4588 variant is a single-nucleotide polymorphism (SNP) located on chromosome 4 within the GC gene. In genetic terms, this variant involves a change in the DNA sequence where a cytosine (C) is replaced by an adenine (A). This specific change is a missense mutation, meaning it alters the protein's structure by substituting one amino acid for another. Specifically, the common C allele encodes the amino acid threonine at position 436 of the vitamin D binding protein, while the A allele encodes lysine. Because this variant is located in a region that influences how the protein is processed and functions, it has been a primary focus for researchers studying how genetics influence nutritional status and metabolic health across different human populations.
The Role of the GC Gene
The GC gene encodes the vitamin D binding protein (VDBP), a multifunctional protein that plays a critical role in the transport and metabolism of vitamin D throughout the body. VDBP acts as the primary carrier for vitamin D metabolites, including 25-hydroxyvitamin D, ensuring they are transported safely through the bloodstream to target tissues. Beyond transport, VDBP is involved in the activation of macrophages and the regulation of inflammatory responses. Because the protein is essential for maintaining stable levels of vitamin D, any structural changes—such as those caused by the rs4588 variant—can potentially affect the protein's binding affinity or its clearance rate from the blood. Understanding this gene is vital for researchers investigating why some individuals maintain different baseline levels of vitamin D despite similar environmental exposures.
Research and Evidence Strength
The association between rs4588 and circulating 25-hydroxyvitamin D levels is well-documented in the scientific literature, with numerous genome-wide association studies confirming a statistical link. However, the evidence regarding the clinical impact of this variant is considered limited. While the A allele is frequently associated with lower measured concentrations of 25-hydroxyvitamin D, it is not necessarily indicative of a clinical deficiency or a disease state. Researchers have explored its potential role in various conditions, including metabolic syndrome, polycystic ovary syndrome, and responses to certain medical treatments, but results are often mixed or specific to certain populations. Because vitamin D levels are influenced by a complex interplay of diet, sunlight exposure, and other genetic factors, rs4588 should be viewed as one piece of a much larger puzzle rather than a definitive predictor of health outcomes.
What You Can Do With This Information
Genetic information regarding rs4588 is primarily educational and should not be used to diagnose health conditions or guide medical decisions. If you are concerned about your vitamin D levels, the most reliable approach is to consult with a healthcare professional who can order standard blood tests to measure your actual serum 25-hydroxyvitamin D concentrations. These clinical tests provide a direct assessment of your current status, which is far more actionable than genetic data alone. If your clinician determines that your levels are outside the optimal range, they may recommend dietary adjustments, lifestyle changes, or supplementation. Always discuss any plans to start or change vitamin D supplementation with your doctor or pharmacist, as they can provide personalized guidance based on your overall health history and specific clinical needs.
How common is this variant?
The rs4588 variant is common globally, with a minor allele frequency (MAF) of approximately 0.28 according to gnomAD data. Frequencies can vary significantly depending on ancestral background.
Frequently asked questions
Does having the A allele mean I am vitamin D deficient?
No, having the A allele does not automatically mean you are deficient. It is associated with lower circulating levels of vitamin D in the blood, but a blood test is required to determine your actual clinical status.
Should I take more vitamin D if I have the A/A genotype?
You should not change your supplement routine based on genetic results alone. Please consult your healthcare provider to discuss your blood test results and determine if supplementation is appropriate for you.
Is rs4588 the same as the GC1 or GC2 polymorphism?
Yes, rs4588 is often discussed in the context of the historical GC1 and GC2 protein phenotypes. The A allele is typically associated with the GC2 phenotype, while the C allele is associated with the GC1 phenotype.
Can I use this information to prevent disease?
This variant is a marker for vitamin D transport, not a direct cause of disease. Focusing on a balanced diet, safe sun exposure, and regular check-ups with your doctor remains the best way to manage your health.
Sources & further reading
Educational information only, last refreshed 10/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4588?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GC
This common variant in the vitamin D-binding protein gene is a primary genomic predictor of circulating 25-hydroxyvitamin D levels and is associated with vitamin D deficiency risk.
A common regulatory variant in the GC gene (encoding Vitamin D Binding Protein) associated with circulating 25-hydroxyvitamin D levels.
This intronic variant in the vitamin D binding protein gene influences circulating 25-hydroxyvitamin D concentrations.
One of the two primary SNPs in the Vitamin D Binding Protein gene that determines a person's Vitamin D status and transport efficiency.